IRTCiRhythm Technologies Inc
$101.74
$7.10
(6.52%)
EarningsJul 30
Mkt Cap$3.58B
Vol796,967.00
Fundamentals
49
Neutral Sentiment
How do you feel about IRTC?
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap PR Newswire TORONTO, ON, June 16, 2026 Issued on behalf of Ventripoint Diagnostics Ltd.As the number of...
PR Newswire
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains...
Yahoo! Finance: News
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know
The consensus price target hints at a 57.2% upside potential for IRHYTHM HLDGS (IRTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Why iRhythm Holdings, Inc. (IRTC) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Comerica Bank Sells 13,381 Shares of iRhythm Technologies $IRTC
Comerica Bank cut its stake in shares of iRhythm Technologies (NASDAQ:IRTC - Free Report) by 47.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat
Citigroup Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price
Citigroup increased their price objective on shares of iRhythm Technologies from $155.00 to $157.00 and gave the company a "buy" rating in a report on Monday...
MarketBeat
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised
iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.
Zacks
iRhythm Technologies (NASDAQ:IRTC) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of iRhythm Technologies (NASDAQ:IRTC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating...
MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Rating Increased to Buy at Wall Street Zen
Wall Street Zen upgraded iRhythm Technologies from a "hold" rating to a "buy" rating in a research report on Sunday...
MarketBeat
Jennison Associates LLC Decreases Stake in iRhythm Technologies $IRTC
Jennison Associates LLC lessened its stake in iRhythm Technologies (NASDAQ:IRTC - Free Report) by 11.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 139,059 shares of the company's stock after selling 18...
MarketBeat
<
1
2
...
>
Advertisement|Remove ads.
Latest IRTC News
View16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap
PR Newswire
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains
Yahoo! Finance: News
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know
Zacks
Advertisement|Remove ads.